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The N-methyl-D-aspartate receptors (NMDARs) are part of a large multiprotein complex
at the glutamatergic synapse. The assembly of NMDARs with synaptic proteins offers
a means to regulate NMDAR channel properties and receptor trafficking, and couples
NMDAR activation to distinct intracellular signaling pathways, thus contributing to the
versatility of NMDAR functions. Receptor-protein interactions at the synapse provide a
dynamic and powerful mechanism for regulating synaptic efficacy, but can also contribute
to NMDAR overactivation-induced excitotoxicity and cellular damage under pathological
conditions. An emerging concept is that by understanding the mechanisms and functions
of disease-specific protein-protein interactions in the NMDAR complex, we may be able to
develop novel therapies based on protein-NMDAR interactions for the treatment of brain
diseases in which NMDAR dysfunction is at the root of their pathogenesis.
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channel complex, signaling pathways
N-methyl-D-aspartate receptors (NMDARs) are a major subtype
of glutamate-gated ion channels at the excitatory synapses in the
central nervous system (CNS), which mediate the flow of sodium
(Na+) and calcium (Ca2+) ions into the cell and potassium
ions (K+) out of the cell. NMDARs are heterotetrameric plasma
membrane channels composed of two obligatory GluN1 and
two modulatory GluN2 (A-D) subunits (Cull-Candy et al., 2001;
Collingridge et al., 2009), although sometimes the GluN2 sub-
units are replaced by GluN3(A-B) subunits (Ulbrich and Isacoff,
2008). NMDARs form a diheteromer when the two GluN2 sub-
units are identical, or a triheteromer when two different GluN2
subunits co-assemble with two identical GluN1 subunits (Ulbrich
and Isacoff, 2008; Collingridge et al., 2010). At resting state,
NMDARs are blocked by the presence of extracellular magnesium
ions (Mg2+) in the channel pore (Vargas-Caballero and Robinson,
2004). As such, the activation and opening of NMDARs is both
voltage-dependent and ligand-gated, and requires the binding of
two ligands, glutamate and either D-serine or glycine (Nong et al.,
2003; Papouin et al., 2012), at a depolarized membrane potential
to relieve Mg2+ block. The function of NMDARs in the CNS
has been extensively studied in both genetic and pharmacological
manipulations. NMDARs play a critical role in a wide range of cel-
lular processes and brain functions, including synaptic plasticity,
addiction and stroke ( Schilström et al., 2006; Collingridge et al.,
2010; Lai et al., 2011). The versatility of NMDAR functions may in
part be attributed to its organization at the synapse. NMDARs are
anchored to the plasma membrane as a multiprotein complex by
binding to more than 70 adhesion proteins ( Naisbitt et al., 1999;
Husi et al., 2000; Grant and O’Dell, 2001). Upon activation, Ca2+
influxes through the opened channel pore and triggers various
intracellular signaling cascades by activating calcium-sensitive
NMDAR-interacting proteins in the multiprotein complex (Lai
et al., 2011; Martin and Wellman, 2011; Lisman et al., 2012).
Increasing evidence suggest that it is these interacting proteins
that confer the versatile functions of NMDARs. In this review,
we will introduce several key NMDAR-interacting proteins in the
NMDAR multiprotein complex and discuss their critical roles
in mediating physiological and pathological functions in the
brain.
INTERACTIONS BETWEEN NMDARs AND CALCIUM
SENSING PROTEINS IN SYNAPTIC PLASTICITY
Two major forms of synaptic plasticity are long-term potentiation
(LTP) and long-term depression (LTD), which are respectively
characterized by long-lasting enhancement and reduction of
synaptic transmission between two adjacent neurons after repet-
itive stimulation (Collingridge et al., 2010, 2004). Many proteins
in the NMDAR complex contribute to these processes, with one
of the most well-characterized proteins being Ca2+/calmodulin-
dependent protein kinase II (CaMKII; Hayashi et al., 2000; Pi
et al., 2010; Lisman et al., 2012), a serine/threonine protein
kinase that is highly enriched in the post-synaptic density region.
CaMKII is a large holoenzyme consisting of 12 identical subunits
(Lisman et al., 2012). Transient Ca2+ influx through the NMDAR
channel pore induces autophosphorylation of CaMKII (at T286
on CaMKIIα subunits or T287 on CaMKIIβ subunits), resulting
in its persistent activation even after intracellular Ca2+ levels
return to baseline (Rellos et al., 2010). As shown by a variety of
real-time imaging studies and binding assays, activated CaMKII
then rapidly and reversibly translocates to the spine and physically
interacts with the 1260-1309aa domain in the carboxyl-terminal
of the GluN2B NMDAR subunit (Figure 1A; Strack and Colbran,
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1998; Bayer et al., 2001, 2006; Otmakhov et al., 2004; Zhang
et al., 2008; Lisman et al., 2012). Although there is a basal level of
association between CaMKII and NMDARs (Leonard et al., 1999),
the translocation of these activated, phosphorylated CaMKII
proteins greatly increases the total number of the kinase at the
postsynaptic site. Introduction of a T286A mutation that prevents
the autophosphorylation and activation of CaMKIIα in mice
significantly impairs NMDAR-dependent LTP in the hippocampal
CA1 area and memory performance in a Morris water maze task
(Giese et al., 1998), suggesting that CaMKII plays a vital role in
NMDAR-dependent synaptic plasticity. This is further supported
by several other lines of evidence. For example, overexpressing a
GluN2B carboxyl-terminal fragment (839-1482aa) that disrupts
the physiological interaction between NMDAR/CaMKII leads to
severe deficits in hippocampal LTP and spatial learning in trans-
genic mice (Zhou et al., 2007). LTP in organotypic hippocampal
slices is impaired either by acute replacement of the synaptic
GluN2B with GluN2A subunit that shows less binding affinity
with CaMKII, or by expression of a mutant synaptic GluN2B
subunit that markedly reduces the binding affinity with CaMKII
(Barria and Malinow, 2005). Taken together, these results suggest
that association of activated CaMKII and NMDARs may be a
necessary step for NMDAR-dependent synaptic plasticity.
How the NMDAR-CaMKII interaction contributes to the
production of LTP is still not fully understood. Several recent
studies report that normal levels of LTP in the CA1 neurons in
adult hippocampal slices can be induced after GluN2B-containing
NMDARs are fully blocked, suggesting that functional activation
of GluN2B-containing NMDARs may not be essential (Köhr et al.,
2003; Liu et al., 2004; Woo et al., 2005; Foster et al., 2010). In
this regard, it is interesting to note that a recent study has found
that GluN2B in the NMDAR complex may function as a key
scaffolding protein at excitatory synapses, and thus plays a critical
role in LTP by recruiting molecules important for LTP through
interacting with them via its cytoplasmic tail (Foster et al., 2010).
Thus, it is likely that GluN2B may have a structural, rather than
a functional, role for LTP production, presumably through the
GluN2B-CaMKII interaction to recruit CaMKII to the activated
synapses, and CaMKII (as a calcium-dependent kinase) in turn
playing an essential role in LTP induction; however, the mechanis-
tic details have not yet been elucidated. Bath application of AC3-1,
a selective peptide inhibitor for CaMKII, to acute hippocampal
slices prevents LTP induction, but has little effect on NMDAR
channel function (Chen et al., 2001). This suggests that although
activated CaMKII is recruited to the synaptic site by interacting
with the GluN2B carboxyl-terminal, it does not regulate NMDAR
channel function during synaptic plasticity. Indeed, several other
studies have reported that activated CaMKII phosphorylates the
S831 residue of the GluA1 subunit of the alpha-amino-3-hydroxy-
5-methyl-4-isoxazolepropionate glutamate receptor (AMPAR), a
major glutamate receptor that mediates fast synaptic transmis-
sion, and increases the single-channel conductance of GluA1-
containing AMPARs (Figure 1A; Barria et al., 1997; Derkach
et al., 1999; Kristensen et al., 2011). This effect can be mimicked
by mutating the S831 residue of GluA1 to the phosphomimic
glutamate residue (Kristensen et al., 2011). Meanwhile, activated
CaMKII can also phosphorylate stargazin (Tomita et al., 2005),
an important postsynaptic scaffolding protein that facilitates the
trafficking of AMPARs from the extrasynaptic space to the synap-
tic region (Figure 1A; Schnell et al., 2002; Tsui and Malenka, 2006;
Opazo et al., 2010; but see Kessels et al., 2009). Taken together,
these processes markedly enhance synaptic transmission so as
to promote the expression of LTP, in particular the initial phase
of LTP. Given that LTP can exist for hours or even weeks, yet
CaMKII is generally inactivated in a relatively short timeframe
(∼1 min) after transient synaptic stimulation (Lee et al., 2009),
it is still unclear whether CaMKII plays any important roles in
the maintenance of late-phase LTP. Furthermore, little is known
about how activated CaMKII participates in LTD, the opposing
form of synaptic plasticity to LTP, although several recent studies
have suggested that autonomous CaMKII can lead to either LTP or
LTD, depending on the phosphorylation state of the control point,
T305/T306 (Pi et al., 2010; Coultrap et al., 2014). Answering these
questions will further uncover details about the physiological
functions of GluN2B-CaMKII interaction in the NMDAR mul-
tiprotein complex, and enhance our understanding of NMDAR-
dependent synaptic plasticity.
Two other important calcium sensors in the NMDAR mul-
tiprotein complex are Ras-Guanine Nucleotide-Releasing Factor
1 (Ras-GRF1) and Ras-GRF2, a family of calcium-dependent
guanine nucleotide exchange factors (GEF) that are predomi-
nantly expressed in adult CNS neurons (Feig, 2011). Structurally,
Ras-GRF1 and Ras-GRF2 share many similarities, and contain
several common functional domains, including the calmodulin-
binding IQ domain, Ras GTPase–activating CDC25 domain and
Rac GTPase-activating DH/PH domain (Feig, 2011). However,
recent studies have shown that Ras-GRF1 and Ras-GRF2 interact
with different NMDAR subunits and play strikingly different roles
in NMDAR-dependent synaptic plasticity (Figure 1B; Feig, 2011).
Knocking out Ras-GRF1 in mice shows minimal effects on both
high frequency stimulation (HFS) and theta burst stimulation
(TBS)-induced LTP in hippocampal slices, but leads to severe
impairments in low frequency stimulation (LFS)-induced LTD (Li
et al., 2006). In contrast, knocking out Ras-GRF2 significantly
impairs both HFS and TBS-induced LTP in hippocampal slices,
whereas LFS-induced LTD is not affected. More strikingly, as
shown by immunoblotting studies in hippocampal brain slices,
Ras-GRF2 mediates signaling from GluN2A-containing NMDARs
to the Ras effector extracellular signal-related protein kinase 1/2
(Erk1/2) mitogen-activated protein (MAP) kinase, a promoter
of LTP, whereas Ras-GRF1 mediates signaling from GluN2B-
containing NMDARs to the Rac effector p38 MAP kinase, a
promoter of LTD (Figure 1B; Li et al., 2006). Given that some
evidence suggests that GluN2A-containing NMDARs promote
LTP whereas GluN2B-containing NMDARs promote LTD (Liu
et al., 2004; Massey et al., 2004), these distinct differences between
Ras-GRF1 and Ras-GRF2 in synaptic plasticity may be partially
explained by the selective interaction between Ras-GRF1 and
the 886-1310aa domain in the carboxyl-terminal of GluN2B
subunit (Krapivinsky et al., 2003). However, to date there is no
clear evidence that supports the presence of a direct interaction
between Ras-GRF2 and the GluN2A subunit, although it is sug-
gested that Ras-GRF2 may localize in the vicinity of GluN2A-
containing NMDARs at the postsynaptic site (Jin and Feig, 2010).
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FIGURE 1 | Interactions between calcium-sensing proteins and NMDARs
in the NMDAR complex and their critical roles in NMDAR-dependent
synaptic plasticity. (A) GluN2B-CAMKII interaction is required for the
induction of long-term potentiation at the excitatory glutermaterigic synapse.
At the postsynaptic domain, transient Ca2+ influx through the NMDAR
induces autophosphorylation (at T286 on CAMKIIα subunits or T287 on
CAMKIIβ subunits) of CaMKII, resulting in its persistent activation and
subsequent translocation to the synaptic site where it binds to the GluN2B
subunit of NMDAR. Activated CaMKII can phosphorylate the S831 residue of
GluA1 subunit of AMPAR that significantly increases the single-channel
conductance of the receptor. Meanwhile, activated CaMKII can also
phosphorylate the postsynaptic scaffolding protein stargazin to facilitate the
trafficking of AMPAR from the extrasynaptic space to the synaptic region so
as to enhance synaptic transmission. (B) Transient calcium influx through
GluN2B-containing NMDAR selectively activates Ras-GRF1 that contributes
to LTD by activating the downstream Rac/p38 pathway, while calcium influx
through GluN2A-containing NMDAR selectively activates Ras-GRF2 that
contributes to LTP by activating the downstream Ras/ERK pathway. There is a
selective physical interaction between Ras-GRF1 and the GluN2B subunit of
NMDAR, but there is no evidence supporting the interaction between
Ras-GRF2 and GluN2A subunit of NMDAR. Interestingly, a recent study
showed that starting at 2 months of age in mice, Ras-GRF1 starts to
contribute to the induction of LTP in the CA1 of hippocampus via the Rac/p38
pathway, however the exact mechanism is still unknown.
Furthermore, given that both Ras-GRF1 and Ras-GRF2 contain
the activation domains for both Ras and Rac GTPases, it is also
important to determine how and why these two proteins are
coupled with different downstream signaling cascades during
LTP and LTD. One explanation is that the selective association
between the synaptic Ras GTPase-activating protein SynGAP and
GluN2B-containing NMDARs in the synapse may help inhibit
Ras-GRF1 from activating the Ras/Erk signaling cascade (Kim
et al., 2005). Alternatively, scaffolding proteins that selectively
associate with either GluN2A or GluN2B may specifically target
Ras-GRF2 and Ras-GRF1 to the Ras and Rac signaling cascades,
respectively (Buchsbaum et al., 2002; Feig, 2011). However, the
detailed mechanism has yet to be determined.
It is noteworthy that the contribution of Ras-GRFs to
NMDAR-dependent synaptic plasticity is highly regulated by
development in mice. Ras-GRF1 and Ras-GRF2 are only coupled
to NMDARs in adult neurons beginning at 20 days of age in mice
(Li et al., 2006), while the guanine nucleotide exchange factor Sos
mediates NMDAR signaling in neurons derived from neonatal
mice (Tian et al., 2004). As mentioned above (Figure 1B), pre-
vious studies report that beginning at 1 month of age, Ras-GRF1
preferentially mediates GluN2B-containing NMDAR-dependent
LTD in the CA1 region of the hippocampus of mice via the
Rac/p38 pathway (Li et al., 2006). Interestingly, beginning at
2 months of age in mice, the role of Ras-GRF1 dramatically
shifts to support the induction of LTP, rather than LTD, in
the CA1 region as a downstream effector of calcium-permeable,
AMPA-type glutamate receptors (Jin et al., 2013). Surprisingly,
this induction of LTP is also mediated by the Rac/p38 pathway,
which was previously thought to be mainly associated with LTD
(Figure 1B; Jin et al., 2013). It is still unclear how these signaling
pathways switch during development, but further investigation is
likely to reveal additional details on the regulatory mechanisms of
Ras-GRF in synaptic plasticity at the NMDAR complex.
INTERACTIONS BETWEEN NMDARs AND G-PROTEIN
COUPLED RECEPTORS (GPCRs) IN PSYCHIATRIC DISORDERS
In addition to coupling to calcium sensing proteins, the NMDAR
complex has extensive functional interactions with G-protein
coupled receptors (GPCRs) through direct physical interac-
tion. An example of this is the reciprocal modulation between
NMDARs and dopamine receptors, a family of GPCRs that
has been implicated in many psychiatric disorders, including
schizophrenia (Seeman, 1987; Dolan et al., 1995).
Dopamine receptors comprise of five subtypes, D1R to D5R,
which can be further classified pharmacologically into D1-like
receptors consisting of D1R and D5R, and D2-like receptors
consisting of D2R, D3R and D4R (Seeman, 1987; Tiberi et al.,
1991; Dolan et al., 1995). Although earlier studies have shown
presynaptic localization (Levey et al., 1993), it is now generally
believed that D1-like receptors are strictly localized on cells that
are postsynaptic to dopaminergic neurons (Hersch et al., 1995;
Yung et al., 1995). In contrast, D2Rs and D3Rs are present
both presynaptically and postsynaptically (Sokoloff et al., 2006).
D1-like receptors increase intracellular cAMP concentrations
through activation of the Gs/olf class of G proteins and subsequent
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FIGURE 2 | Crosstalks between dopamine and NMDA receptors
mediated by physical interactions between the two receptors.
(A) Physical interaction between D1R and NMDAR reciprocally regulate
receptor properties and trafficking. The carboxyl tails of NMDAR subunits
GluN1 and GluN2A individually binds to separate sites on the D1R carboxyl
tail. D1R activation inhibits NMDAR currents through the physical
interaction between GluN2A and D1R by reducing the surface number of
NMDARs, which appears to impact working memory. In contrast, activation
of D1R promotes the dissociation of GluN1 and D1R. This allows the
recruitment of CaM and PI3K to GluN1, which activate PI3K-dependent cell
survival signals and promote cell survival. (B) The carboxyl tail of GluN2B
binds to the third intracellular loop of the D2R. Activation of D2R promotes
its association with GluN2B, which in turn disrupts the binding between
GluN2B and CaMKII. This leads to a decrease in CaMKII activity, resulting
in reduced phosphorylation of Serine1303 of GluN2B and hence reduced
NMDAR currents.
activation of adenylyl cyclase (AC), whereas D2-like receptors
couple to the Gi/o class of G proteins to inhibit AC (Kebabian
et al., 1972; Monsma et al., 1990). Numerous studies have demon-
strated extensive crosstalk between DRs and NMDARs via direct
physical association between the receptors (Figure 2, for a review,
see Beaulieu and Gainetdinov, 2011).
D1Rs co-immunoprecipitates with both GluN1 and GluN2A
subunits of the NMDAR in rat hippocampal tissue, suggesting a
physical interaction between the two receptors (Lee et al., 2002).
Further in vitro experiments confirm that the carboxyl tails of
both the GluN1 subunit and GluN2A subunit (but not GluN2B)
individually bind to the carboxyl tails of D1Rs (but not that
of D5Rs). The 387-416aa domain of the D1R carboxyl-tail is
sufficient for D1R-GluN1 binding, while the 417-446aa domain
is required for the D1R-GluN2A interaction, suggesting that two
distinct protein-protein interactions exist between the receptors.
The binding between NMDARs and D1Rs occurs in the absence of
D1R agonists, and D1R activation reduces the interaction between
D1R-GluN1 but not that between D1R-GluN2A (Lee et al., 2002).
The functional consequences of these two interactions sig-
nificantly differ. Following D1R stimulation with its agonist
SKF81297, the D1R-GluN2A interaction functions to reduce the
surface expression of NMDARs and hence the receptor-gated
currents in both transfected cells and hippocampal neurons
through a PKA/PKC independent pathway (Lee et al., 2002).
It should be noted that SKF81297, in addition to activating
D1Rs, has previously been shown to reduce NMDAR currents
via a direct blockade of the NMDAR channel pore (Figure 2A,
Cui et al., 2006). However, dissociation of D1R-GluN2A inter-
action using an interference peptide significantly reverses the
attenuation of NMDAR currents, strongly arguing for a crucial
role of the physical coupling between the two receptors, rather
than a direct channel blockade, in mediating D1R activation-
induced NMDAR inhibition (Lee et al., 2002). As overactivation
of NMDAR is crucial for excitotoxic neuronal death (Lai et al.,
2011), this reduction of surface expression of NMDARs would
be expected to decrease Ca2+ influx and hence be neuropro-
tective. However, peptide-mediated dissociation of D1R-GluN2A
does not affect neuronal survival following a NMDA insult.
Instead, the uncoupling of D1R-GluN1 following D1R activation
confers neuroprotection through the recruitment of calmodulin
and phosphatidylinositol 3-kinase to GluN1, which activates cell-
survival signals (Figure 2A, Lee et al., 2002). These data suggest
that D1R activation-induced inhibition of NMDAR-mediated
currents and excitotoxicity are differentially mediated by distinct
subunit-specific interactions in the NMDAR complex, further
highlighting that specific protein-protein interactions dictate the
functional outcomes of the NMDAR complex.
Further studies have demonstrated that D1R and NMDAR
interactions may also reciprocally regulate receptor trafficking
and surface expression in a NMDAR subunit-specific manner.
D1Rs directly interact with the GluN1 subunit in cytoplasmic
compartments, where they are retained, and the presence of
the GluN2B subunit drives the translocation and insertion of
the D1R-GluN1 receptor complex into the plasma membrane in
medium spiny neurons and cotransfected cells (Fiorentini et al.,
2003). This suggests that D1Rs and NMDARs are assembled
as constitutive heteromeric complexes in cytoplasmic compart-
ments prior delivery to functional sites, a process that does not
depend on receptor activation (Fiorentini et al., 2003). Further-
more, constitutive association with GluN2B-containing NMDARs
abolishes agonist-induced D1R internalization and stabilizes
D1Rs at the post-synaptic density (Fiorentini et al., 2003). In
contrast, although GluN2A-containing NMDARs can also recruit
Frontiers in Cellular Neuroscience www.frontiersin.org June 2014 | Volume 8 | Article 160 | 4
Fan et al. The multifunctional NMDAR protein complex
D1Rs to the cell surface, this effect depends on NMDAR stim-
ulation. In cotransfected cells, activation of GluN2A-containing
NMDARs increases their physical association with D1Rs, which
drives the insertion of D1Rs into the plasma membrane (Pei et al.,
2004). These differences in agonist dependency may perhaps be
attributed to functional differences between GluN2A or GluN2B-
containing NMDARs (for a review, see Traynelis et al., 2010).
In addition to regulating D1R surface expression, NMDAR acti-
vation can also reduce D1R lateral diffusion in medium spiny
neurons via increased GluN1-D1R interaction, which stabilizes
D1Rs at the synapse (Scott et al., 2006). It should be noted,
however, that the observed increase in D1R surface levels may
be transient or restricted to certain neuronal populations in
vivo, as a 90% reduction in GluN1 expression in mice did not
impair striatal D1R pharmacology and function (Ramsey et al.,
2008).
Conversely, the binding between D1Rs and NMDARs also
modulates NMDAR surface dynamics at glutamatergic synapses,
which offers a more direct means to regulate synaptic plasticity.
D1R activation, which reduces D1R-GluN1 interaction at the
perisynapse, allows NMDARs to laterally diffuse into the post-
synaptic density where they favor LTP, an effect that was recapit-
ulated by dissociating D1R-GluN1 binding with an interference
peptide (Ladepeche et al., 2013). Dissociation of D1R-GluN1
upon D1R activation promotes CaMKII-GluN1 interaction and
increases CaMKII activity, which in turn upregulates NMDAR-
mediated LTP in primary hippocampal neurons and promotes
spatial working memory in the delayed match-to-place version
of the water maze in intact animals (Nai et al., 2010). While
this effect may be cautiously interpreted as a result of physical
dissociation between D1R-GluN1, it should be noted that D1R
activation may also affect synaptic plasticity through protein
phosphatase-dependent pathways (Frey et al., 1993; Stramiello
and Wagner, 2008) as well as network mechanisms (Xu and Yao,
2010). However, the relative contribution of each mechanism
remains to be seen.
The long-form D2R, which is preferentially involved in post-
synaptic signaling compared to short-form D2R (Lindgren et al.,
2003) interacts with the carboxyl-tail of the GluN2B subunit
of NMDARs in the post-synaptic density of striatal neurons.
In contrast to D1Rs, this interaction is not mediated by the
D2R carboxyl-tail, but by a TKRSSRAFRA motif situated in the
N-terminal of the third intracellular loop of D2Rs (Liu et al.,
2006). The interaction between D2Rs and NMDARs is receptor-
and subunit- specific: D3Rs, which are similar to D2Rs and also
belong to the D2-class of dopamine receptors, do not associate
with the GluN2B subunit, and D2Rs do not interact with the
GluN1 subunit (Liu et al., 2006).
Activation of D2Rs with its agonist quinpirole inhibits
NMDAR currents in acutely dissociated medium-sized striatal
neurons, which can be blocked by disrupting D2R-GluN2B
physical interaction (Liu et al., 2006). Acute treatment with
cocaine, a psychostimulant known to exert its effects through
both dopaminergic and glutamatergic signaling, enhances D2R-
GluN2B coupling in the striatum. In turn, this increased
association disrupts GluN2B-CaMKII binding, resulting in
decreased CaMKII activity, reducing phosphorylation of GluN2B
at the Serine 1303 residue, and thereby resulting in reduced
NMDAR currents (Figure 2B, Liu et al., 2006). Cocaine-enhanced
D2R-GluN2B interaction seems to be specific to the striatum, as it
was not observed in the hippocampus or frontal cortex. The D2R-
GluN2B interaction may play a role in eliciting the locomotor
effects of cocaine. In rats, systemic disruption of D2R-GluN2B
interaction prior cocaine treatment markedly reverses the uncou-
pling between GluN2B-CaMKII induced by cocaine and rescues
GluN2B S1303 phosphorylation in the striatum without affecting
basal GluN2B-CaMKII interactions. Furthermore, blocking D2R-
GluN2B interactions significantly, though not completely, reduces
cocaine-stimulated locomotion in rats (Liu et al., 2006). This
suggests the existence of other factors that contribute to the full-
scale motor response to cocaine.
Going forward, it would be particularly interesting to see
whether these findings extend to prefrontal dopaminergic neu-
rotransmission. The prefrontal cortex, together with other corti-
colimbic areas including the cingulate gyrus and hippocampus,
are implicated as part of the dysfunctional network that underlies
schizophrenia (Fletcher, 1998). Furthermore, NMDAR hypofunc-
tion during development is gradually emerging as a convergence
point for disease progression in schizophrenia (Snyder and Gao,
2013). Together, these findings, with the observation that the
D1R-GluN1 physical interaction reciprocally regulates D1R and
NMDAR surface expression and function, prompts the question
of whether it is the initial failure in glutamatergic signaling that
leads to reduced dopaminergic neurotransmission in schizophre-
nia through perturbed protein (receptor)-NMDAR interactions
in the NMDAR complex.
In summary, NDMARs and dopamine receptors directly
interact to reciprocally regulate receptor surface expression,
channel properties and downstream intracellular signaling cas-
cades. Together with functional interactions through shared
downstream signaling molecules, the physical coupling between
NMDARs and dopamine receptors adds another layer of regu-
lation to both neurotransmitter systems to fine-tune neuronal
function and behavior.
NMDAR COMPLEX AS A CRUX IN ISCHEMIC NEURONAL
DAMAGES
Intensive investigations into the mechanisms and functions of
protein-protein interactions in the NMDAR complex have not
only further advanced our understanding of the roles of NMDARs
in brain function and dysfunction, but also led to the develop-
ment of novel protein-NMDAR interaction-based therapeutics
for treating brain disorders in which NMDAR dysfunction is
at the root of their pathogenesis. Well-characterized examples
of such therapeutics are the newly developed and promising
interventions that protect neurons against excitotoxic/ischemic
damages following stroke by disrupting direct or indirect interac-
tions between NMDARs and neuronal death signaling molecules,
such as neuronal Nitric Oxide Synthase (nNOS; Aarts et al., 2002;
Zhou et al., 2010), death associated protein kinase 1 (DAPK1; Tu
et al., 2010; Fan et al., 2014) and PTEN (Zhang et al., 2013).
Overactivation of the NMDAR triggers rapid Ca2+ influx
that could lead to excitotoxic neuronal death. This excitotoxicity
is considered a common pathological step leading to neuronal
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FIGURE 3 | Dissociating the NMDAR cell death signaling complex
protects neurons against excitotoxic/ischemic damage following
stroke. Left panel: Following excitotoxic NMDA stimulation or ischemic
insult, the post-synaptic scaffolding protein PSD-95 couples nNOS to the
GluN2B subunit of the NMDAR, thus positioning nNOS for a more effective
activation and production of NO by calcium influx through the NMDAR
channel pore, leading to increased neuronal death. Middle panel: The
interference peptide Tat-GluN2B9c competitively disrupts the interaction
between PSD-95 and GluN2B, and hence dissociates PSD-95 and nNOS
from the NMDAR complex. By doing so, the peptide reduces the
NMDA-induced production of NO, and hence decreases NO-mediated
excitotoxic/ischemic neuronal death. Right panel: Similarly, the
interference peptide nNOS-N1−133 disrupts the binding between PSD-95
and nNOS, thereby dissociating nNOS from the NMDAR complex. By
reducing the NMDAR-mediated activation of nNOS, the peptide reduces
NO production and hence excitotoxic/ischemic neuronal death.
loss in many brain disorders, from acute brain injuries such as
stroke to chronic neurodegenerative diseases such as Huntington’s
disease (Lai et al., 2014). Yet direct blockade of NMDARs has
failed as a neuroprotective strategy in stroke, at least in part due
to intolerable psychosomatic side effects as a result of blocking
normal NMDAR function and/or relatively narrow windows for
effective intervention (Ikonomidou and Turski, 2002; Lai et al.,
2014). In an effort to overcome the shortcomings of NMDAR
antagonists, scientists have focused on druggable protein-protein
interactions in the NMDAR complex that specifically lead to neu-
ronal death. These have led to not only the identification of several
well-characterized cell death-promoting molecules that can form
neuronal death signaling complexes downstream of NMDARs via
either direct or indirect interactions with NMDAR subunits, but
also the development of numerous promising interventions that
protect neurons from brain insults by specifically disrupting these
interactions (Lai et al., 2014).
One of the most exciting bench-to-bedside examples is the
recent development of effective neuroprotectants based on dis-
rupting the GluN2B-Post synaptic density-95 (PSD-95)-nNOS
cell death complex (Christopherson, 1999; Sattler et al., 1999),
which was first characterized over a decade ago. PSD-95 is a
membrane-associated guanylate kinase (MAGUK) concentrated
at glutamatergic synapses and is involved in synapse stabilization
and plasticity (El-Husseini et al., 2000). nNOS catalyzes the pro-
duction of nitric oxide (NO), a diffusible signaling molecule
implicated in synaptic plasticity (Bredt et al., 1990) and glutamate
neurotoxicity (Dawson et al., 1991). By binding to both nNOS and
GluN2B through its different PDZ domains, PSD-95 functions
as a scaffolding protein to bring nNOS to the NMDAR complex
(Kornau et al., 1995; Brenman et al., 1996). Following excitotoxic
stimuli and/or ischemic insults, PSD-95 tethers nNOS to GluN2B,
thus positioning nNOS to be more effectively activated by Ca2+
influx through the NMDAR channel pore and generation of the
cytotoxic compound NO (Figure 3, left panel) (Dawson et al.,
1991; Sattler et al., 1999).
In a proof-of-concept study, Aarts et al. (2002) disrupted
this signaling complex with a 20-mer interference peptide Tat-
NR2B9c, which comprises of the last nine amino acids of the
carboxyl tail of GluN2B required for its interaction with PSD-
95 and the 11-mer Tat protein transduction domain that renders
the peptide plasma membrane permeable. The rationale behind
the initial peptide design is to use it to disrupt GluN2B-PSD-
95 interaction and hence to prevent PSD-95 from recruiting
nNOS to the NMDAR complex, thereby reducing NO produc-
tion and NO-mediated neuronal death (Figure 3, middle panel),
although a later study suggests that the peptide may also some-
how reduce the interaction between PSD-95 and nNOS (Cui
et al., 2007). When bath applied to primary neuronal cultures
and acute brain slices, Tat-NR2B9c does not affect NMDAR-
mediated currents or Ca2+ fluxes, but can selectively disrupt
the interaction between PSD-95 and NMDARs through com-
petition with the binding of native GluN2B subunit (but not
GluN2A) to PSD95, and thereby reduce the generation of NO
and excitotoxicity (Aarts et al., 2002). When given systemati-
cally, a single dose of Tat-NR2B9c administered either before
or after ischemic insults reduces ischemic brain damage with
concurrent improvements in neurological scores in rats subjected
to transient middle cerebral artery occlusion (MCAo), a well-
characterized focal ischemia stroke model (Aarts et al., 2002).
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Similar neuroprotective effects are seen by disrupting the inter-
action between PSD-95 and nNOS with an interference peptide
derived from the PSD-95 binding domain of nNOS (nNOS-
N1−133; Figure 3, right panel; Zhou et al., 2010). Following viral
infection of rats with a vector expressing this peptide, nNOS-
N1−133 effectively blocks the interaction between the two proteins
and significantly reduces stroke-induced ischemic damage (Zhou
et al., 2010).
These initial attempts at targeting GluN2B-PSD-95-nNOS
signaling pathway for the treatment of stroke was quickly fol-
lowed by a well-designed study in a focal ischemia model in
gyrencephalic nonhuman primates (Cook et al., 2012a,b) and a
successful phase 2, double-blind, placebo-controlled multicenter
clinical trial of neuroprotection in procedurally-induced stroke
(Hill et al., 2012). Treatment with Tat-NR2B9c (also named as
NA-1 in these studies) results in reduced ischemic brain damage
compared to the placebo treatment, as evidenced by diffusion
weighted magnetic resonance imaging. These exciting bench-to-
bedside results provide great promises for further understand-
ing disease-specific protein-protein interactions in the NMDAR
complex and thereby developing novel and effective therapeu-
tics for brain diseases involving NMDAR-mediated neuronal
degeneration.
CONCLUSIONS
Increasing evidence suggest that the NMDAR is not a solo player
in the regulation of many brain functions and dysfunctions. By
associating with various membrane receptors and extracellular
or intracellular proteins in the complex, the NMDAR can con-
tribute to various physiological processes such as learning and
memory, and brain disorders such as stroke, schizophrenia and
addiction. Many NMDAR-interacting proteins have recently been
identified in the NMDAR complex; however, in the past only
a few protein-protein interactions have been characterized in
detail. Since NMDARs are widely expressed in all brain areas,
it would be paramount to know whether and how the NMDAR
plays vital roles in both brain function and dysfunction through
these diverse protein-protein interactions in the receptor com-
plex. Further investigation on this topic will not only deepen
our understanding of the functions of the NMDAR multiprotein
complex, but also greatly facilitate the development of innova-
tive therapeutics in treating various NMDAR dysfunction-related
brain disorders.
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